J.M. Coetzee as Latin American Writer: Simultaneous Translation—Foreignness—World Literature

Domínguez, César

doi:10.1007/978-3-662-62332-9_6

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Besides acting as nanoparticles and therapeutic materials delivery vehicles, EVs derived from certain cell types (e.g., stem cells, immune cells, tubular cells, cancer cells) possess intrinsic self-therapeutic efficacy and can be utilized directly as therapeutic biomolecules [155][156][157][158][159]. Through the presence of natural surface proteins (e.g., integrins, L-selectin, CD44, CXCR4) or engineered targeting moieties (e.g., Kim-1-binding peptide, RVG peptide), EVs exhibit efficient localization to the diseased kidney, leading to improvements in renal function and injury by inhibiting apoptosis, inflammation, and fibrosis, while promoting cell proliferation, angiogenesis, and autophagy.…”

Section: Extracellular Vesicles (Evs)mentioning

confidence: 99%

Recent Advances in Cell Membrane Coated-Nanoparticles as Drug Delivery Systems for Tackling Urological Diseases

et al. 2023

View full text Add to dashboard Cite

Recent studies have revealed the functional roles of cell membrane coated-nanoparticles (CMNPs) in tackling urological diseases, including cancers, inflammation, and acute kidney injury. Cells are a fundamental part of pathology to regulate nearly all urological diseases, and, therefore, naturally derived cell membranes inherit the functional role to enhance the biopharmaceutical performance of their encapsulated nanoparticles on drug delivery. In this review, methods for CMNP synthesis and surface engineering are summarized. The application of different types of CMNPs for tackling urological diseases is updated, including cancer cell membrane, stem cell membrane, immune cell membrane, erythrocytes cell membranes, and extracellular vesicles, and their potential for clinical use is discussed.

show abstract